180 related articles for article (PubMed ID: 2962732)
1. Peripheral blood lymphocytes from patients with cancer lack interleukin-2 receptors.
Hakim AA
Cancer; 1988 Feb; 61(4):689-701. PubMed ID: 2962732
[TBL] [Abstract][Full Text] [Related]
2. Peripheral blood lymphocytes from patients with cancer lack interleukin-2 (IL-2) receptor expression: isolation of mRNA encoding IL-2R.
Hakim AA
Cancer Detect Prev; 1988; 12(1-6):59-71. PubMed ID: 2460238
[TBL] [Abstract][Full Text] [Related]
3. Functional heterogeneity correlates with structural heterogeneity of breast carcinoma acid-soluble glycoproteins.
Hakim AA
Proc Soc Exp Biol Med; 1987 Jun; 185(2):158-76. PubMed ID: 3554260
[TBL] [Abstract][Full Text] [Related]
4. A mechanism by which human breast carcinoma cells escape the host immune system.
Hakim AA
Neoplasma; 1988; 35(6):691-705. PubMed ID: 3265486
[TBL] [Abstract][Full Text] [Related]
5. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-2 induces cytotoxic activity in lymphocytes from regional axillary nodes of breast cancer patients.
Bonilla F; Alvarez-Mon M; Merino F; de la Hera A; Alés JE; España P; Durántez A
Cancer; 1988 Feb; 61(4):629-34. PubMed ID: 3257405
[TBL] [Abstract][Full Text] [Related]
7. Cytolysis of mammary tumor targets by resting, interleukin-2 stimulated and in vitro cultured peripheral blood lymphocytes from breast cancer patients.
Brenner BG; McCrea EL; Margolese RG
Anticancer Res; 1988; 8(4):653-8. PubMed ID: 3263077
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.
Harel-Bellan A; Bertoglio J; Quillet A; Marchiol C; Wakasugi H; Mishall Z; Fradelizi D
J Immunol; 1986 Apr; 136(7):2463-9. PubMed ID: 3005412
[TBL] [Abstract][Full Text] [Related]
9. The interaction of recombinant IL-2 with human resting lymphocytes: blocking effects of monoclonal antibodies to IL-2 receptors.
Iseki R; Koide Y; Ueda R; Kondo N; Hamuro J; Yoshida TO
Microbiol Immunol; 1987; 31(1):59-74. PubMed ID: 2438541
[TBL] [Abstract][Full Text] [Related]
10. Limiting dilution analysis (LDA) of cells responding to recombinant interleukin-2 without previous stimulation: evidence that all responding cells are lymphokine-activated potent effectors.
Vie H; Bonneville M; Sondermeyer P; Moreau JF; Soulillou JP
Immunology; 1986 Mar; 57(3):351-7. PubMed ID: 3082744
[TBL] [Abstract][Full Text] [Related]
11. Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.
Itoh K; Platsoucas CD; Balch CM
J Exp Med; 1988 Oct; 168(4):1419-41. PubMed ID: 3262710
[TBL] [Abstract][Full Text] [Related]
12. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
13. Regulation of human large granular lymphocyte and T cell growth and function by recombinant interleukin 2: induction of interleukin 2 receptor and promotion of growth of cells with enhanced cytotoxicity.
Yamada S; Ruscetti FW; Overton WR; Herberman RB; Birchenall-Sparks MC; Ortaldo JR
J Leukoc Biol; 1987 Jun; 41(6):505-17. PubMed ID: 3110337
[TBL] [Abstract][Full Text] [Related]
14. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines.
Perussia B; Ramoni C; Anegon I; Cuturi MC; Faust J; Trinchieri G
Nat Immun Cell Growth Regul; 1987; 6(4):171-88. PubMed ID: 2960890
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 2 receptor expression by activated HNK-1+ granular lymphocytes: a requirement for their proliferation.
Abo T; Miller CA; Balch CM; Cooper MD
J Immunol; 1983 Oct; 131(4):1822-6. PubMed ID: 6413578
[TBL] [Abstract][Full Text] [Related]
16. Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients.
Chen YM; Yang WK; Ting CC; Tsai WY; Yang DM; Whang-Peng J; Perng RP
Chest; 1997 Oct; 112(4):960-6. PubMed ID: 9377959
[TBL] [Abstract][Full Text] [Related]
17. Impaired natural killer cell lysis in breast cancer patients with high levels of psychological stress is associated with altered expression of killer immunoglobin-like receptors.
Varker KA; Terrell CE; Welt M; Suleiman S; Thornton L; Andersen BL; Carson WE
J Surg Res; 2007 May; 139(1):36-44. PubMed ID: 17292412
[TBL] [Abstract][Full Text] [Related]
18. Peripheral blood natural killer cell activity in human breast cancer patients and its modulation by T-cell growth factor and autologous plasma.
Brenner BG; Benarrosh S; Margolese RG
Cancer; 1986 Aug; 58(4):895-902. PubMed ID: 3487379
[TBL] [Abstract][Full Text] [Related]
19. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
[TBL] [Abstract][Full Text] [Related]
20. The IL-2 receptor beta chain (p70): role in mediating signals for LAK, NK, and proliferative activities.
Siegel JP; Sharon M; Smith PL; Leonard WJ
Science; 1987 Oct; 238(4823):75-8. PubMed ID: 3116668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]